BGI - About the company
BGI is a public company based in Shenzhen (China), founded in 1999. It operates as a Provider of services in genome sequencing. BGI has raised an undisclosed amount in funding. The company has 627 active competitors, including 61 funded and 66 that have exited. Its top competitors include companies like Strand Life Sciences, Enara Bio and Berry Genomics.
Company Details
Provider of services in genome sequencing. The company provides services in large-scale sequencing of human, plant, and animal genome. The company's major scientific accomplishments include sequencing the genome of an Asian person, the giant panda, and the human gut microbiome. It also contributed to the Human Genome Project and the rice-genome-sequencing initiative. The company's sequencing platform includes BGIseq.
- Website
- www.bgi.com
- Email ID
- *****@bgi.com
- Phone Number
- +86 **********
- Registered Address
- 34, Symfonivej, Herlev, 2730
Key Metrics
Founded Year
1999
Location
Shenzhen, China
Stage
Public
Latest Funding Round
Investors
Ranked
2nd among 627 active competitors
Employee Count
3,038 as on Sep 30, 2026
Similar Companies
Exit Details
Public
Legal entities associated with BGI
BGI is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
BGI EUROPE A/S CIN: 32931340 , Denmark, Active | May 16, 2010 | - | 25 (As on Mar 31, 2024) |
BGI's IPO details
BGI got listed on Jul 14, 2017.
Click here to take a look at BGI's IPO in detail
Sign up to download BGI's company profile
BGI's funding and investors
BGI has raised funding over 2 rounds. Its first funding round was on Jan 01, 2015. Its latest funding round was a Post IPO round on Feb 22, 2021 for $*****. 1 investor participated in its latest round. BGI has 17 institutional investors.
Here is the list of recent funding rounds of BGI:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 22, 2021 | 5948941 | Post IPO | 2593297 | 6412751 | 3687925 | 5197499 |
Jan 01, 2015 | 9733732 | Grant (prize money) | 9683624 | 9953668 | 8305164 |
View details of BGI's funding rounds and investors
BGI's founders and board of directors
Founder? Claim ProfileBGI's employee count trend
BGI has 3,038 employees as of Sep 26. Here is BGI's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
BGI's Competitors and alternates
Top competitors of BGI include Strand Life Sciences, Enara Bio and Berry Genomics. Here is the list of Top 10 competitors of BGI, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Strand Life Sciences 2000, Bengaluru (India), Acquired | Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery | $34.9M | 74/100 | |
2nd | Provider of services in genome sequencing | - | 66/100 | ||
3rd | Enara Bio 2016, Oxford (United Kingdom), Series B | Developer of T-cell based cancer-cell interface for therapeutics | $84.1M | 53/100 | |
4th | Berry Genomics 2010, Beijing (China), Public | Provider of genetic testing products and tests | $16M | 50/100 | |
5th | Provider of services for research application across life sciences industries | - | 49/100 | ||
6th | AI-based oncology therapy plan solution for professionals | $43M | 49/100 | ||
7th | Amplia Therapeutics 2000, North Melbourne (Australia), Public | Developer of therapies for treating cancer and pulmonary fibrosis | - | - | 47/100 |
8th | Transnetyx 2000, Memphis (United States), Acquired | Developer of automated-genotyping services for murine cell lines | - | 47/100 | |
9th | Macrogen 1997, Seoul (South Korea), Public | Provider of a platform for next-generation sequencing | - | 47/100 | |
10th | Products and services in molecular biology | $56.4M | 46/100 |
Looking for more details on BGI's competitors? Click here to see the top ones
BGI's Investments and acquisitions
BGI has not made any acquisitions yet. BGI has made 5 investments.Here is the list of latest three $investments:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jan 15, 2019 | Investments | 2010 | Bangkok (Thailand) | |
Jan 14, 2019 | Investments | 2015 | Beijing (China) | |
Apr 27, 2017 | Investments | 2013 | Cambridge (United Kingdom) |
See all investments by BGI
Reports related to BGI
Here is the latest report on BGI's sector:
News related to BGI
Media has covered BGI for a total of 2 events in the last 1 year, 1 of them has been about company updates.
•
•
•
•
•
Bgi Genomics Secures 950 M Rmb Genetic Testing Contract In Saudi ArabiaBioSpectrum Asia•Mar 17, 2025•BGI, National Unified Procurement Company
•
•
New Health Care Era in Kazakhstan: Astana Genetic Center will offer state -of -the -art genetic testingPR Newswire•Jul 26, 2024•BGI
•
BGI establishes intelligent lab in China for initiating colorectal cancer risk assessmentBioSpectrum Asia•May 13, 2024•BGI
•
•
Are you a Founder ?
FAQs about BGI
Explore our recently published companies
- Bandhan TMX - Bhavnagar based, 2004 founded, Unfunded company
- Schauenburg - South Africa based, Unfunded company
- Proyector24.es - Barcelona based, Unfunded company
- Women Fitness - Agra based, 2000 founded, Unfunded company
- Dr. Reddy's in Netherlands - Netherlands based, 1984 founded, Public company
- Slummy Single Mummy - Taunton based, 2009 founded, Unfunded company
